NCT02082340.

Trial name or title	Innovative approach in tuberculosis care in Armenia
Methods	Study design: Randomized, efficacy study, parallel assignment, open label Inclusion criteria: Diagnosis of drug‐sensitive TB. Age 18 years old and above. Understanding and reading in Armenian. Completion of the intensive treatment phase. Exclusion criteria: Involvement in the home‐based TB treatment programme of the National TB Control Office.
Participants	Target sample size: 400 participants; age minimum: 18 years; age maximum: N/A; gender: both
Interventions	Self‐administered drug intake strategy, TB knowledge and socio‐psychological counselling session, SMS text messages, phone calls, educational leaflet
Outcomes	Primary: TB treatment success rates (time frame: patients will be followed for the duration of ambulatory phase of treatment, an expected average of 4 months). Secondary: Depression status of TB patients. Family support towards TB patients. Knowledge about TB infection. Quality of life of TB patients. Stigma level towards TB patients. TB treatment adherence. Time frame: At baseline, 1, and 3 months after starting the ambulatory phase of the treatment and upon completion of the treatment (an expected average of 4 months after starting the ambulatory phase of the treatment)
Starting date	Date of registration: 4 March 2014 Date of first enrolment: March 2014 Last refreshed on: 31 March 2014 Recruitment status: Active, not recruiting
Contact information	URL:http://clinicaltrials.gov/show/NCT02082340 Varduhi Petrosyan American University of Armenia Fund
Notes	Study ID: NCT02082340 Register: ClinicalTrials.gov Location: Armenia Source of funding: Grand Challenges Canada